Relief, eager anticipation for many Americans ahead of FDA decision on booster shots
Bill Oxford/iStock(NEW YORK) -- For Mitchell Kronenberg, answers on the Johnson & Johnson vaccine can't come soon enough. A 42-year-old dad living outside Charlotte, North Carolina, Kronenberg enrolled in a clinical trial for the single-dose vaccine and got his shot last January. Since then, he's been patiently waiting for U.S. federal regulators to tell him what to do next to stay safe: Should he get another Johnson & Johnson shot? Switch to Moderna or Pfizer? Is his single-shot vaccination enough to protect him from spreading the virus to his unvaccinated 4-year-old son? &...
Source: mycentraloregon.com
